What is the future of Seed to Sale in Cannabis ERP?
Article by Jason Warnock,
Cannabis Advisor for Applied DNA Sciences

Starting with Proposition 215 and the first Medical Cannabis legalization law in California in 1996, regulatory bodies, law enforcement, and governments have been struggling to maintain control over the legal and illegal cannabis business. Even now, as the industry has exploded with over 30 states and almost 30 countries worldwide allowing either medical use or adult-use cannabis, the mandate remains how to monitor, tax and control the legal trade, while limiting the grey or black market.

In each case, the governing body has required a “seed to sale” protocol or monitoring system to record the cultivation, manufacturing, disposal, and ultimately sale of cannabis products to the dispensary or retail locations.

With a rush of a new industry, many new software companies sprung up to support the market and in many States, the government-mandated a specific singular platform to better collectively manage and report the data. Unfortunately, the ability to move almost all the early companies from the grey and black market into the regulated regime caused a significant hurdle for many producers to adopt. When coupled with large data and security breaches from the initial versions of the leading Seed to Sale company’s platforms, the industry and governance were caught switching between
programs and creating bottlenecks in the ability of these producers to legally cultivate or move product to market.